%0 Journal Article
%T SNPs in DNA repair or oxidative stress genes and late subcutaneous fibrosis in patients following single shot partial breast irradiation
%A Elisabetta Falvo
%A Lidia Strigari
%A Gennaro Citro
%A Carolina Giordano
%A Genoveva Boboc
%A Fabiana Fabretti
%A Vicente Bruzzaniti
%A Luca Bellesi
%A Paola Muti
%A Giovanni Blandino
%A Paola Pinnar¨°
%J Journal of Experimental & Clinical Cancer Research
%D 2012
%I BioMed Central
%R 10.1186/1756-9966-31-7
%X A total of 57 breast cancer patients who underwent SSPBI were genotyped for SNPs (single nucleotide polymorphisms) in XRCC1, XRCC3, GST and RAD51 by Pyrosequencing technology. Univariate analysis (ORs and 95% CI) was performed to correlate SNPs with the risk of developing ¡Ư G2 fibrosis or fat necrosis.A higher significant risk of developing ¡Ư G2 fibrosis or fat necrosis in patients with: polymorphic variant GSTP1 (Ile105Val) (OR = 2.9; 95%CI, 0.88-10.14, p = 0.047).The presence of some SNPs involved in DNA repair or response to oxidative stress seem to be able to predict late toxicity.ClinicalTrials.gov: NCT01316328Conservative surgery followed by adjuvant radiotherapy(RT) to whole breast has become widely accepted as a standard of care for women with early breast cancer. In particular, a number of studies [1-4] reported that most (81%-100%) intra breast tumour recurrences after breast conserving surgery (BCS) occur in close proximity to the tumour bed, so providing the rationale of Partial Breast Irradiation (PBI) an adjuvant RT limited to the Index Area i.e. the area of breast only including the primary tumour bed and the surrounding tissue. In addition, the delivery of radiation dose to smaller target volume by PBI is expected to reduce radiation-related toxicity. Thus, the so-called Accelerated Partial Breast Irradiation (APBI), where only the Index Area is irradiated in 1-10 fractions at high dose/fraction, has been promoted in phase I-III trials designed to test feasibility and equivalence with standard Whole Breast Irradiation (WBI) in properly selected low risk early breast cancer patients after BCS [5]. However, a remarkably high rate of late toxicity has been reported by some Authors a few years after follow up with this APBI approach [6,7]. A high late toxicity rate was also observed in our cohort, after single shot of PBI (SSPBI) [8]. Thus the possibility to predict patient outcome based on marker genes correlated with radio-induced toxicity was investig
%K Radiotherapy
%K Breast cancer
%K Polymorphisms
%K Late effects
%K Fibrosis
%U http://www.jeccr.com/content/31/1/7